down arrow

SOPHiA GENETICS SA

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: CH1125843347
USD
5.02
-0.03 (-0.59%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

4.935.18

52 Week

2.585.30
Valuation
Technical
Day's Volume

CASH

101.2 k

Shareholding (Mar 2025)

FII

25.39%

Held by 20 FIIs

DII

71.62%

Held by 6 DIIs

Promoter

0.00%

How big is SOPHiA GENETICS SA?

22-Jun-2025

As of Jun 18, SOPHiA GENETICS SA has a market capitalization of 195.15 million, with net sales of 67.17 million and a net profit of -66.18 million over the latest four quarters. As of Dec 24, shareholder's funds are 96.49 million and total assets are 156.41 million.

As of Jun 18, SOPHiA GENETICS SA has a market capitalization of 195.15 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 67.17 million, while the sum of net profit for the same period is -66.18 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 96.49 million and total assets of 156.41 million.

Read More

What does SOPHiA GENETICS SA do?

22-Jun-2025

SOPHiA GENETICS SA is a micro-cap software company specializing in data-driven medicine, with recent net sales of $18 million and a net loss of $17 million. The company has a market cap of $195.15 million and does not pay dividends.

Overview:<BR>SOPHiA GENETICS SA operates in the software products industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 18 Million (Quarterly Results - Mar 2025)<BR>- Most recent Net Profit: -17 Million (Quarterly Results - Mar 2025)<BR>- Market-cap: USD 195.15 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.62<BR>- Return on Equity: -77.68%<BR>- Price to Book: 2.28<BR><BR>Contact Details:<BR>No Company Details Available.

Read More

Should I buy, sell or hold SOPHiA GENETICS SA?

22-Jun-2025

Is SOPHiA GENETICS SA technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, SOPHiA GENETICS SA shows mixed technical signals with a mildly bullish short-term trend but has underperformed the S&P 500 significantly over the past year and three years.

As of 2 September 2025, the technical trend for SOPHiA GENETICS SA has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD shows a mildly bullish trend. The daily moving averages are mildly bullish, suggesting some short-term positive momentum. However, the Bollinger Bands on a monthly basis are bearish, and the KST indicates a bullish weekly trend but a bearish monthly trend. Overall, the stock is facing mixed signals with no clear trend from Dow Theory and no significant signals from RSI or OBV.<BR><BR>In terms of performance, the stock has underperformed against the S&P 500 across multiple periods, with a 1-year return of -27.0% compared to the S&P 500's 17.14%, and a 3-year return of 20.83% versus 70.41% for the benchmark. This indicates a weaker performance relative to the broader market.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Jun 25

  • INTEREST(9M) At USD 1.24 MM has Grown at inf%
  • ROCE(HY) Lowest at -74.09%
  • DEBT-EQUITY RATIO (HY) Highest at -40.43 %
2

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Software Products

stock-summary
Market cap

USD 224 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.59

stock-summary
Return on Equity

-96.10%

stock-summary
Price to Book

2.93

Revenue and Profits:
Net Sales:
18 Million
(Quarterly Results - Jun 2025)
Net Profit:
-22 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
46.36%
0%
46.36%
6 Months
65.95%
0%
65.95%
1 Year
49.85%
0%
49.85%
2 Years
22.74%
0%
22.74%
3 Years
119.21%
0%
119.21%
4 Years
-61.12%
0%
-61.12%
5 Years
0%
0%
0.0%

SOPHiA GENETICS SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
SOPHiA GENETICS SA Hits New 52-Week High of USD 5.30

SOPHiA GENETICS SA Hits New 52-Week High of USD 5.30

SOPHiA GENETICS SA achieved a new 52-week high of USD 5.30 on October 31, 2025, up from a low of USD 2.58. The company, with a market cap of USD 224 million, has seen a 4.17% performance increase over the past year, despite ongoing financial challenges.

Read More
SOPHiA GENETICS SA Hits New 52-Week High at USD 5.30

SOPHiA GENETICS SA Hits New 52-Week High at USD 5.30

SOPHiA GENETICS SA achieved a new 52-week high of USD 5.30 on October 30, 2025, significantly up from its low of USD 2.58. With a market cap of USD 224 million, the company operates at a loss and has a negative return on equity, indicating challenges in the competitive software industry.

Read More

Is SOPHiA GENETICS SA technically bullish or bearish?

As of 2 September 2025, the technical trend for SOPHiA GENETICS SA has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD shows a mildly bullish trend. The daily moving averages are mildly bullish, suggesting some short-term positive momentum. However, the Bollinger Bands on a monthly basis are bearish, and the KST indicates a bullish weekly trend but a bearish monthly trend. Overall, the stock is facing mixed signals with no clear trend from Dow Theory and no significant signals from RSI or OBV. In terms of performance, the stock has underperformed against the S&P 500 across multiple periods, with a 1-year return of -27.0% compared to the S&P 500's 17.14%, and a 3-year return of 20.83% versus 70.41% for the benchmark. This indicates a weaker performance relative to the broader market....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.51%
EBIT Growth (5y)
-9.53%
EBIT to Interest (avg)
-51.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
0.46
Tax Ratio
2.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
42.90%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.44
EV to EBIT
-2.44
EV to EBITDA
-2.83
EV to Capital Employed
4.78
EV to Sales
2.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-195.88%
ROE (Latest)
-77.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 6 Schemes (2.98%)

Foreign Institutions

Held by 20 Foreign Institutions (25.39%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 15.82% vs 4.64% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -47.37% vs 28.97% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.30",
          "val2": "15.80",
          "chgp": "15.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-16.20",
          "val2": "-13.00",
          "chgp": "-24.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-22.40",
          "val2": "-15.20",
          "chgp": "-47.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,012.80%",
          "val2": "-950.30%",
          "chgp": "-6.25%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.49% vs 31.09% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.89% vs 9.61% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "65.20",
          "val2": "62.40",
          "chgp": "4.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-58.90",
          "val2": "-68.60",
          "chgp": "14.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "0.60",
          "chgp": "216.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-62.50",
          "val2": "-79.00",
          "chgp": "20.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,035.40%",
          "val2": "-1,233.10%",
          "chgp": "19.77%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
18.30
15.80
15.82%
Operating Profit (PBDIT) excl Other Income
-16.20
-13.00
-24.62%
Interest
0.60
0.00
Exceptional Items
0.10
0.10
Consolidate Net Profit
-22.40
-15.20
-47.37%
Operating Profit Margin (Excl OI)
-1,012.80%
-950.30%
-6.25%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 15.82% vs 4.64% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -47.37% vs 28.97% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
65.20
62.40
4.49%
Operating Profit (PBDIT) excl Other Income
-58.90
-68.60
14.14%
Interest
1.90
0.60
216.67%
Exceptional Items
0.40
0.00
Consolidate Net Profit
-62.50
-79.00
20.89%
Operating Profit Margin (Excl OI)
-1,035.40%
-1,233.10%
19.77%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 4.49% vs 31.09% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 20.89% vs 9.61% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About SOPHiA GENETICS SA stock-summary
stock-summary
SOPHiA GENETICS SA
Software Products
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."